Home Xellia Enters 4 Year Collaboration To Develop New Antibiotics To Combat Multi-Drug Resistant Bacteria
 

Keywords :   


Xellia Enters 4 Year Collaboration To Develop New Antibiotics To Combat Multi-Drug Resistant Bacteria

2013-02-26 05:02:00| drugdiscoveryonline Home Page

Xellia Pharmaceuticals, a fully integrated specialty pharmaceutical company focusing on the global anti-infective market, announced recently that it is developing new antibiotics effective against multi-drug resistant (MDR), Gram-negative bacteria

Tags: year develop collaboration combat

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
27.11 PSA10 () SCR
27.111108
27.11
27.11
27.11SAKEROCK/ 0
27.11Influence THEROW
27.11 A
27.11FIRSTSPEAR
More »